Pfizer Inc.
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same

Last updated:

Abstract:

The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.

Status:
Grant
Type:

Utility

Filling date:

24 May 2018

Issue date:

23 Mar 2021